US Patent 9359316 Prodrugs of phenolic TRPV1 agonists
Patent 9359316 was granted and assigned to Concentric Analgesics, Inc. on June, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+235 characters)
Article
Patent abstract
Described herein are compounds, pharmaceutical compositions and medicaments that include such compounds, and methods of using such compounds to modulate transient receptor potential vanilloid 1 receptor (TRPV1) activity.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Craig Husfeld0
John F. Donovan0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09359316 Prodrugs of phenolic TRPV1 agonists US Patent 9359316 Prodrugs of phenolic TRPV1 agonists
Infobox
Patent Number
093593160
Patent Number
93593160
Edits on 5 Oct, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
093593160
Date of Patent
June 7, 2016
0Patent Application Number
147433750
Date Filed
June 18, 2015
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09359316 Prodrugs of phenolic TRPV1 agonists
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09359316
Date of patent
June 7, 2016
Patent application number
14743375
Date Filed
June 18, 2015
Patent primary examiner
Find more entities like US Patent 9359316 Prodrugs of phenolic TRPV1 agonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
